cGxP.wire https://validator.w3.org/feed/docs/rss2.html Gallant Advances Stem Cell Therapy for Canine OA Alebund Pharma Completes Phase 3 AP301 Enrollment Clear Scientific Gains FDA Fast Track for CS-1103 LTZ Therapeutics Raises $38M for Immunotherapy Pipeline Diakonos Gains FDA Fast Track for DOC1021 Melanoma Smith+Nephew Unveils New Chronic Wound Care Technologies CARBOGEN AMCIS Passes Unannounced NMPA GMP Audit Partner Therapeutics Gains FDA Priority Voucher for BIZENGRI® Lilly Expands Indiana Manufacturing With $4.5B Eden Files NRC Permit for U.S. Isotope Production Nuvation Bio Expands IBTROZI FDA Lung Cancer Filing Nona Biosciences Appoints Josh Xiao as New CSO Belay Diagnostics Summit Improves CNS Cancer Detection Bayer to Acquire Perfuse Therapeutics in $2.45B Deal BioOra and WZTL Expand Global CAR-T Therapy Rights Hoth Therapeutics Advances HT-001 Phase 2a Trial Norgine Gains Australia Approval for PEDMARQSI® Citius Oncology Secures $36.5M for LYMPHIR Growth Calla Lily Starts FREEDOM Trial for Callavid Platform Spago Nanomedical Advances Tumorad-01 With MTD Milestone Arrowhead Pharmaceuticals and Madrigal Announce MASH Deal Lupin Wins FDA Approval for UCD Oral Liquid Drug Guardant Health Gains FDA Nod for Breast Cancer CDx Neuraly Inc Advances NLY01 Phase 2 MS Trial AbbVie Showcases IBD Data for Skyrizi and Rinvoq Verana Health Enhances Clinical Trial Enrollment Tech Viridian Therapeutics Reports Positive REVEAL-2 Results Johnson & Johnson Reports OTTAVA Surgical Robot Data Amylyx Pharmaceuticals Launches Avexitide Access Program Alpha Tau Medical Ltd. Showcases Alpha DaRT Data Mirum Volixibat Achieves Phase 2b Success in PSC Trial Ortho Development Launches Trivicta Hip Stem in US Takeda Canada Secures REVESTIVE Reimbursement in BC Lilly Omvoh Shows 4-Year UC Disease Clearance Results ImmunityBio to Present ANKTIVA Data at AUA 2026 Sensei Doses First Patient in PIKTOR Breast Trial Insulet Launches EVOLVE Study for Closed Loop System Lannett Secures FDA Nod for Interchangeable Insulin Nanobiotix Updates Phase 3 NANORAY-312 Protocol Opus Genetics Enters FDA RDEP Program for OPGx-LCA5 Cellenkos Secures FDA IND Clearance for CK0802 in GVHD Trial Johnson & Johnson Highlights CAPLYTA Superiority in MDD Study Telix Pharmaceuticals Publishes TLX250-Px Kidney Study TriSalus Life Sciences Launches PREDICTT Trial Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence Caris Life Sciences Gains MolDX Approval for ChromoSeq MMI Launches REMIND Trial Using Symani System UCB to Acquire Candid Therapeutics in $2.2B Immunology Deal Castle Biosciences Unveils TissueCypher Data at DDW 2026 BriaCell Gains FDA Clearance for Breast Cancer Trial